Adicet Bio, Inc. (ACET) has reported a reduced loss for the second quarter compared to the same period last year, surpassing Wall Street expectations.
The company's net loss stood at $29.90 million, or $0.33 per share. This marks an improvement from the previous year's second-quarter loss of $32.40 million, or $0.75 per share.
According to Thomson Reuters, analysts had, on average, predicted a loss of $0.36 per share, typically excluding special items.
Summary of Adicet Bio, Inc.'s Q2 earnings (GAAP):
- Loss: $29.90 million compared to $32.40 million last year.
- Earnings per share (EPS): $0.33 compared to $0.75 last year.
